Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;16(6):7879-7889.
doi: 10.3892/mmr.2017.7641. Epub 2017 Sep 27.

PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)

Affiliations
Review

PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)

Hua-Zhong Ying et al. Mol Med Rep. 2017 Dec.

Abstract

The platelet‑derived growth factor (PDFG) signaling pathway exerts persistent activation in response to a variety of stimuli and facilitates the progression of hepatic fibrosis. Since this pathway modulates a broad spectrum of cellular processes, including cell growth, differentiation, inflammation and carcinogenesis, it has emerged as a therapeutic target for hepatic fibrosis and liver‑associated disorders. The present review exhibits the current knowledge of the role of the PDGF signaling pathway and its pathological profiles in hepatic fibrosis, and assesses the potential of inhibitors which have been investigated in the experimental hepatic fibrosis model, in addition to the clinical challenges associated with these inhibitors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic representation of the PDGF signaling pathway. PDGF, platelet-derived growth factor; PDGFR, PDGF receptor; miR, microRNA; PI3K, phosphatidylinositol 3-kinase; PLCγ, phospholipase Cγ; Sos, son of sevenless homolog; JAK1, tyrosine-protein kinase JAK1; PDK1, 3-phosphoinositide-dependent protein kinase 1; Akt, RAC-α serine/threonine protein kinase; PTEN, phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN; ROCK, Rho-associated protein kinase 1; MLC, membrane protein MLC; NF-κB, nuclear factor-κB; IKKα, inhibitor of NF-κB kinase subunit α; C/EBPβ, CCAAT/enhancer-binding protein β; STAT, signal transducer and activator of transcription; MEK, dual specificity mitogen-activated protein kinase kinase; Erk, extracellular signal-regulated kinase; AP-1, transcription factor AP-1; TIMP, metalloproteinase inhibitor; c-Myc, myc proto-oncogene protein; CT1, cardiotrophin 1.
Figure 2.
Figure 2.
Recent challenges and future strategies for the treatment of hepatic fibrosis.

Similar articles

Cited by

References

    1. Bonder A, Tapper EB, Afdhal NH. Contemporary assessment of hepatic fibrosis. Clin Liver Dis. 2015;19:123–134. doi: 10.1016/j.cld.2014.09.007. - DOI - PubMed
    1. Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: Concept to treatment. J Hepatol. 2015;62(1 Suppl):S15–S24. doi: 10.1016/j.jhep.2015.02.039. - DOI - PubMed
    1. Jacobs F, Wisse E, De Geest B. The role of liver sinusoidal cells in hepatocyte-directed gene transfer. Am J Pathol. 2010;176:14–21. doi: 10.2353/ajpath.2010.090136. - DOI - PMC - PubMed
    1. Tacke F, Weiskirchen R. Update on hepatic stellate cells: Pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol. 2012;6:67–80. doi: 10.1586/egh.11.92. - DOI - PubMed
    1. Yin C, Evason KJ, Asahina K, Stainier DY. Hepatic stellate cells in liver development, regeneration, and cancer. J Clin Invest. 2013;123:1902–1910. doi: 10.1172/JCI66369. - DOI - PMC - PubMed

MeSH terms

Substances